Management of herpes simplex virus epithelial keratitis

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose of review

To review recent advancements in the management of herpes simplex virus (HSV) epithelial keratitis.

Recent findings

Trifluridine eye drop, acyclovir (ACV) ointment, ganciclovir gel, and oral ACV are still the main therapeutic agents. Cryopreserved amniotic membrane has been recently used as an adjuvant treatment. Resistance to ACV has become a concerning issue. The animal models of HSV vaccine are able to reduce HSV keratitis. New antivirals are under development.

Summary

Current cases of HSV epithelial keratitis are manageable with available medications, but new advancements are required to decrease disease burden in the future. HSV vaccine can be revolutionary.

Related Topics

    loading  Loading Related Articles